Best Traditional Pharmaceuticals Companies in France
The 41 best Traditional Pharmaceuticals companies in France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Pharmatis.
- HTF Market Intelligence
- Coherent Market Insights
Our analysis of 50 Traditional Pharmaceuticals companies
$3.2b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2016.
Ranked: Best Traditional Pharmaceuticals companies in France
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmatis Manufacturer of liquids and ointments | $34M | 109 mo ago | Acquired | M. Jean-Louis Vouzellaud CEO | 2001 | WordPressPleskMySQL+25 | — | — |
| 2 | Horus Pharma Developer of ophthalmology pharmaceutical products | $25M | 53 mo ago | Series B | Martine Claret Co-Founder & President | 2003 | PrestaShopPleskApple iCloud Mail+13 | 117 patents Topical hyaluronic acid emulsions and innovative dispensing/packaging devices for dermatology. | — |
| 3 | BioAlliance Pharma Developer of medicines for cancer, HIV, and opportunistic infections | $15M | 263 mo ago | Public | Judith Greciet CEO | 1997 | — | 197 patents Mucosal bioadhesive sustained-release carriers and drug‑loaded nanoparticles for oncology and inflammation | — |
| 4 | INPHARMASCI Provider of website development and client support services | $685K | 55 mo ago | Funding Raised | — | 1983 | — | — | — |
| 5 | Servier Developer of pharmaceutical therapies for various therapeutic areas | — | 54 mo ago | Funding Raised | — | 1954 | WordPressApple iCloud MailMicrosoft 365+21 | — | — |
| 6 | Pierre Fabre Provider of pharma, dermo-cosmetics, OTC and consumer health products | — | 64 mo ago | Funding Raised | — | 1962 | DrupalApple iCloud MailMicrosoft 365+17 | 2,127 patents Dermatological and cosmetic formulations for skin, hair, sunscreen, and microbiome therapeutics. | — |
| 7 | H2 Pharma Manufacturer of non-sterile liquid pharmaceutical specialties | — | 70 mo ago | Late Stage | — | 2006 | WordPressMySQLPHP+17 | 20 patents Patents concentrated in health & consumer products | — |
| 8 | CLL Pharma Developer of generic pharmaceutical products | — | 182 mo ago | Deadpooled | Claude Laruelle CEO & President | 1995 | — | 45 patents Patents concentrated in health & consumer products | — |
Top 8 Traditional Pharmaceuticals companies in France
#1
Series B · St Laurent du Var, Provence Alpes Cote d Azur · founded 2003 · 220 employees$25.2Mraised▾
Developer of ophthalmology pharmaceutical products
- Mar 2022Series B$25.2M
- Mar 2015Grant (prize money)$54.3K
- Oct 2014Grant (prize money)$63K
#2
Funding Raised · Prouvy, Hauts de France · founded 1983 · 220 employees$685Kraised▾
Provider of website development and client support services. The company offers assistance and information through guides and a forum. A client area is also available. The website is currently under construction.
- Jan 2022Grant (prize money)$685K
#3
Acquired · Estrees Saint Denis, Hauts de France · founded 2001 · 250 employees$34.3Mraised▾
Pharmatis manufactures generic finished formulations specialized in liquids and ointments. Their products are of various therapeutic categories including antibiotics, analgesics, antifungal, dermatological, and others.
- Jul 2017PE$34.3M
#4
Public · Paris, Ile de France · founded 1997$14.7Mraised▾
BioAlliance Pharma develops and markets innovative products, especially in the fields of opportunistic infections and chemotherapy complications. In April 2014, BioAlliance announces its merger with the Danish company TopoTarget to form Onxeo.
- Sep 2004Series C$2.5M
#5
Funding Raised · Suresnes, Ile de France · founded 1954 · 44 employees—raised▾
Developer of pharmaceutical therapies for various therapeutic areas. This includes treatments for cancers, cardio-metabolic diseases, and neurological disorders. A focus is placed on precision medicine and the development of targeted therapies. The company also offers generic drugs. Patient needs are considered throughout the drug lifecycle, from research and development to access and post-market surveillance. The company actively engages in research and development collaborations.
#6
Funding Raised · Castres, Occitanie · founded 1962 · 164 employees—raised▾
Provider of pharma, dermo-cosmetics, OTC and consumer health. Its therapeutic areas include Oncology, Gynecology, Neuropsychiatry, Urology, Cardiology, and Diabetes. In Consumer Healthcare, it makes products in the areas of Oral healthcare, Nicotine patches, dermatology, and more. A number of dermo-cosmetic brands, such as Klorane, Avene, Ducray, and Elancyl belong to Pierre Fabre.
#7
Late Stage · Fontenay le Fleury, Ile de France · founded 2006 · 40 employees—raised▾
Manufacturer of non-sterile liquid pharmaceutical specialties. It controls the entire drug value chain, from sourcing raw materials to finished product production, encompassing development and regulatory affairs. The company utilizes advanced technology and strict Good Manufacturing Practices in a state-of-the-art facility. Production lines are automated, ensuring high yields and adherence to deadlines. Specialization in production equipment, including lines for various bottle types and liquid sachets, allows for efficient batch production. A key innovation is the perfect separation of technical and pharmaceutical areas, minimizing contamination risks. Internal quality control labs ensure compliance with standards.
- Oct 2020PE—
#8
Deadpooled · Nice, Provence Alpes Cote d Azur · founded 1995 · 11 employees—raised▾
CLL Pharma is involved in the development of generic drugs, peptides, and innovative galenical formulations. Clientele includes companies like Ranbaxy, Sandoz, Teva, Merck etc among others.
- 2011Series A—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Traditional Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Drug Discovery is moving in France
A read on the academic research around Drug Discovery — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,323 France-affiliated papers.
- Centre National de la Recherche Scientifique423
- Inserm242
- École Polytechnique Fédérale de Lausanne79
- Université Paris Cité70
- Institute of Cancer Research64
- Computational biology22→115
- Chemical space10→59
- Virtual screening6→48
- Small molecule4→38
- Enzyme1→28
- Computational biology30→77
- In silico6→37
- Pharmacology5→35
- Virtual screening12→42
- Docking (animal)6→36
- Drug development1→20
- Computational biology12→28
- Bioinformatics2→16
- Data science4→17
- Pharmacology5→16
Where drug discovery is researched across France
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing drug discovery patents in France
France drug discovery patent filing is cooling — 80,553 filings from 8,000 assignees (2016–2025), led by Oreal, Centre NAT RECH Scient, INST NAT Sante RECH MED; annual filings 8768→6874.
- Oreal34729
- Centre NAT RECH Scient15303
- INST NAT Sante RECH MED11326
- Sanofi10449
- Sanofi Aventis9517
- Servier LAB8025
- PF Medicament3206
- Pasteur Institut3163
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.